131 related articles for article (PubMed ID: 10669645)
1. Glucosylated glycerophosphoethanolamines are the major LDL glycation products and increase LDL susceptibility to oxidation: evidence of their presence in atherosclerotic lesions.
Ravandi A; Kuksis A; Shaikh NA
Arterioscler Thromb Vasc Biol; 2000 Feb; 20(2):467-77. PubMed ID: 10669645
[TBL] [Abstract][Full Text] [Related]
2. Glycated phosphatidylethanolamine promotes macrophage uptake of low density lipoprotein and accumulation of cholesteryl esters and triacylglycerols.
Ravandi A; Kuksis A; Shaikh NA
J Biol Chem; 1999 Jun; 274(23):16494-500. PubMed ID: 10347212
[TBL] [Abstract][Full Text] [Related]
3. Delay of copper-catalyzed oxidation of low density lipoprotein by in vitro enrichment with choline or ethanolamine plasmalogens.
Jürgens G; Fell A; Ledinski G; Chen Q; Paltauf F
Chem Phys Lipids; 1995 Aug; 77(1):25-31. PubMed ID: 7586089
[TBL] [Abstract][Full Text] [Related]
4. Glycation and oxidation: a role in the pathogenesis of atherosclerosis.
Lyons TJ
Am J Cardiol; 1993 Feb; 71(6):26B-31B. PubMed ID: 8434558
[TBL] [Abstract][Full Text] [Related]
5. Why is glycated LDL more sensitive to oxidation than native LDL? A comparative study.
Sobal G; Menzel J; Sinzinger H
Prostaglandins Leukot Essent Fatty Acids; 2000 Oct; 63(4):177-86. PubMed ID: 11049692
[TBL] [Abstract][Full Text] [Related]
6. Glycation and glycoxidation of low-density lipoproteins by glucose and low-molecular mass aldehydes. Formation of modified and oxidized particles.
Knott HM; Brown BE; Davies MJ; Dean RT
Eur J Biochem; 2003 Sep; 270(17):3572-82. PubMed ID: 12919321
[TBL] [Abstract][Full Text] [Related]
7. Effect of alpha-tocopherol on LDL oxidation and glycation: in vitro and in vivo studies.
Li D; Devaraj S; Fuller C; Bucala R; Jialal I
J Lipid Res; 1996 Sep; 37(9):1978-86. PubMed ID: 8895064
[TBL] [Abstract][Full Text] [Related]
8. In vivo and in vitro evidence for the glycoxidation of low density lipoprotein in human atherosclerotic plaques.
Imanaga Y; Sakata N; Takebayashi S; Matsunaga A; Sasaki J; Arakawa K; Nagai R; Horiuchi S; Itabe H; Takano T
Atherosclerosis; 2000 Jun; 150(2):343-55. PubMed ID: 10856526
[TBL] [Abstract][Full Text] [Related]
9. p-hydroxyphenylacetaldehyde, an aldehyde generated by myeloperoxidase, modifies phospholipid amino groups of low density lipoprotein in human atherosclerotic intima.
Heller JI; Crowley JR; Hazen SL; Salvay DM; Wagner P; Pennathur S; Heinecke JW
J Biol Chem; 2000 Apr; 275(14):9957-62. PubMed ID: 10744670
[TBL] [Abstract][Full Text] [Related]
10. Phospholipids and oxophospholipids in atherosclerotic plaques at different stages of plaque development.
Ravandi A; Babaei S; Leung R; Monge JC; Hoppe G; Hoff H; Kamido H; Kuksis A
Lipids; 2004 Feb; 39(2):97-109. PubMed ID: 15134136
[TBL] [Abstract][Full Text] [Related]
11. Glucose oxidation and low-density lipoprotein-induced macrophage ceroid accumulation: possible implications for diabetic atherosclerosis.
Hunt JV; Bottoms MA; Clare K; Skamarauskas JT; Mitchinson MJ
Biochem J; 1994 May; 300 ( Pt 1)(Pt 1):243-9. PubMed ID: 8198540
[TBL] [Abstract][Full Text] [Related]
12. Effect of glycation on the properties of lipoprotein(a).
Makino K; Furbee JW; Scanu AM; Fless GM
Arterioscler Thromb Vasc Biol; 1995 Mar; 15(3):385-91. PubMed ID: 7749849
[TBL] [Abstract][Full Text] [Related]
13. Low-density-lipoprotein (LDL)-bound flavonoids increase the resistance of LDL to oxidation and glycation under pathophysiological concentrations of glucose in vitro.
Wu CH; Lin JA; Hsieh WC; Yen GC
J Agric Food Chem; 2009 Jun; 57(11):5058-64. PubMed ID: 19489629
[TBL] [Abstract][Full Text] [Related]
14. Glucose influence on copper ion-dependent oxidation of low density lipoprotein.
Ghaffari MA; Mojab S
Iran Biomed J; 2009 Jan; 13(1):59-64. PubMed ID: 19252679
[TBL] [Abstract][Full Text] [Related]
15. Lipoxygenase contributes to the oxidation of lipids in human atherosclerotic plaques.
Folcik VA; Nivar-Aristy RA; Krajewski LP; Cathcart MK
J Clin Invest; 1995 Jul; 96(1):504-10. PubMed ID: 7615823
[TBL] [Abstract][Full Text] [Related]
16. Anti-modified LDL antibodies, LDL-containing immune complexes, and susceptibility of LDL to in vitro oxidation in patients with type 2 diabetes.
Mironova MA; Klein RL; Virella GT; Lopes-Virella MF
Diabetes; 2000 Jun; 49(6):1033-41. PubMed ID: 10866057
[TBL] [Abstract][Full Text] [Related]
17. Lipid advanced glycosylation: pathway for lipid oxidation in vivo.
Bucala R; Makita Z; Koschinsky T; Cerami A; Vlassara H
Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6434-8. PubMed ID: 8341651
[TBL] [Abstract][Full Text] [Related]
18. Glycation of low-density lipoproteins by methylglyoxal and glycolaldehyde gives rise to the in vitro formation of lipid-laden cells.
Brown BE; Dean RT; Davies MJ
Diabetologia; 2005 Feb; 48(2):361-9. PubMed ID: 15660260
[TBL] [Abstract][Full Text] [Related]
19. Cosupplementation with coenzyme Q prevents the prooxidant effect of alpha-tocopherol and increases the resistance of LDL to transition metal-dependent oxidation initiation.
Thomas SR; Neuzil J; Stocker R
Arterioscler Thromb Vasc Biol; 1996 May; 16(5):687-96. PubMed ID: 8963727
[TBL] [Abstract][Full Text] [Related]
20. Formation of N-(hexanoyl)ethanolamine, a novel phosphatidylethanolamine adduct, during the oxidation of erythrocyte membrane and low-density lipoprotein.
Tsuji K; Kawai Y; Kato Y; Osawa T
Biochem Biophys Res Commun; 2003 Jul; 306(3):706-11. PubMed ID: 12810076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
